Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Noah Goodman currently holds 50,195.44 shares of Kymera Therapeutics, Inc. (KYMR), valued at approximately $0. This represents their equity stake as Chief Business Officer.
Based on SEC Form 4 filings, Noah Goodman has been a net seller of KYMR stock. They have purchased $0 and sold $121.2K worth of shares.
Noah Goodman's most recent insider trade was on Apr 14, 2026, when they sold 1,347 shares at $90.00 per share.
Noah Goodman serves as Chief Business Officer at Kymera Therapeutics, Inc. (KYMR). They have executed 3 insider transactions totaling $121.2K over their tenure at the company.
Noah Goodman holds the position of Chief Business Officer at Kymera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Noah Goodman has shown a selling trading pattern, with $0 in total purchases and $121.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Noah Goodman was on Apr 14, 2026, when they sold $121.2K worth of KYMR shares. This transaction involved 1,347 shares at $90.00 per share.
Noah Goodman currently owns 50,195.44 shares of Kymera Therapeutics, Inc. (KYMR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Noah Goodman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Noah Goodman has 3 Form 4 filings on record as an insider at Kymera Therapeutics, Inc..
Set alerts for Noah Goodman and 40,000+ other insiders.